ConductScience.org, home

Paper8934049

A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy.

Hendry JH and 8 others. Clin Oncol (R Coll Radiol), 1996. Cited by 105 papers, by iCite.

Cite this record

ConductScience Library. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Papers, record 8934049. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8934049

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy.
PubMed
Journal
Clin Oncol (R Coll Radiol)
PubMed
Year
1996
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
105
iCite
Relative citation ratio, by iCite
3.97
iCite
Revised in PubMed
2019-09-14
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hendry JHJ H
2Bentzen SMS M
3Dale RGR G
4Fowler JFJ F
5Wheldon TET E
6Jones BB
7Munro AJA J
8Slevin NJN J
9Robertson AGA G

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Head and Neck NeoplasmsMajor topic
Radiotherapy, Computer-AssistedMajor topic
Uterine Cervical NeoplasmsMajor topic
Brachytherapy
Dose-Response Relationship, Radiation
Female
Humans
Models, Theoretical
Radioisotope Teletherapy
Radiotherapy Dosage
Time Factors

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in11527305Outcomes of cervix cancer treatments in 1993.https://conductscience.org/library/papers/11527305

Source PubMed

Download CSV of comments and corrections

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.

PMIDTitleJournalYearIn PapersSource
42908819Calendar-defined missed-workday gaps in radiotherapy: a site- and phase-stratified audit with linkage sensitivity analyses.Front Oncol2026https://conductscience.org/library/papers/42908819PubMed
41621013Managing unplanned radiotherapy interruptions in Italy: results from an AIRO survey.Clin Transl Oncol2026https://conductscience.org/library/papers/41621013PubMed
40525433Oral Metronomic Chemotherapy in Nasopharyngeal Carcinoma with Radiotherapy Interruptions: A Lesson Learned from the Lockdown Due to COVID-19.Recent Pat Anticancer Drug Discov2026https://conductscience.org/library/papers/40525433PubMed
39468713Elevated α/β ratio after hypofractionated radiotherapy correlated with DNA damage repairment in an experimental model of prostate cancer.J Radiat Res2024https://conductscience.org/library/papers/39468713PubMed
39109283Management and outcomes of breast cancer patients with radiotherapy interruption.Front Oncol2024https://conductscience.org/library/papers/39109283PubMed
37232849Investigating Predictive Factors of Dysphagia and Treatment Prolongation in Patients with Oral Cavity or Oropharyngeal Cancer Receiving Radiation Therapy Concurrently with Chemotherapy.Curr Oncol2023https://conductscience.org/library/papers/37232849PubMed
37091186Effect of radiotherapy interruption on nasopharyngeal cancer.Front Oncol2023https://conductscience.org/library/papers/37091186PubMed
36852328Machine Learning-Based Multiomics Prediction Model for Radiation Pneumonitis.J Oncol2023https://conductscience.org/library/papers/36852328PubMed
35907097Towards personalised dosimetry in patients with liver malignancy treated with 90Y-SIRT using in vivo-driven radiobiological parameters.EJNMMI Phys2022https://conductscience.org/library/papers/35907097PubMed
32307313[Practical update of total dose compensation in case of temporary interruption of external radiotherapy in the COVID-19 pandemic context].Cancer Radiother2020https://conductscience.org/library/papers/32307313PubMed
32095592Awareness and surveillance of radiation treatment schedules reduces head and neck overall treatment time.Tech Innov Patient Support Radiat Oncol2019https://conductscience.org/library/papers/32095592PubMed
31574418Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).Eur J Cancer2019https://conductscience.org/library/papers/31574418PubMed
30858768Management of interruptions in radiotherapy treatments: Adaptive implementation in high workload sites.Rep Pract Oncol Radiother2019https://conductscience.org/library/papers/30858768PubMed
29273054Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictor.Radiat Oncol2017https://conductscience.org/library/papers/29273054PubMed
27815711The "rocky treatment course": identifying a high-risk subgroup of head and neck cancer patients for supportive interventions.Support Care Cancer2017https://conductscience.org/library/papers/27815711PubMed
26549990Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature.Rep Pract Oncol Radiother2015https://conductscience.org/library/papers/26549990PubMed
25806305Radiotherapy for single station N2 NSCLC.Transl Lung Cancer Res2014https://conductscience.org/library/papers/25806305PubMed
25460164A matter of timing: identifying significant multi-dose radiotherapy improvements by numerical simulation and genetic algorithm search.PLoS One2014https://conductscience.org/library/papers/25460164PubMed
24526276Competing causes of death and medical comorbidities among patients with human papillomavirus-positive vs human papillomavirus-negative oropharyngeal carcinoma and impact on adherence to radiotherapy.JAMA Otolaryngol Head Neck Surg2014https://conductscience.org/library/papers/24526276PubMed
23787766Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response.Phys Med Biol2013https://conductscience.org/library/papers/23787766PubMed

See all 29 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8934049

GET https://conductscience.org/api/papers/v1/8934049/cited_by?page=2